Kevin Young
2012
In 2012, Kevin Young earned a total compensation of $4.6M as Former Executive Vice President, Commercial Operations at Gilead Sciences, a 3% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $904,400 |
|---|---|
| Option Awards | $1,543,029 |
| Salary | $756,274 |
| Stock Awards | $1,353,044 |
| Other | $7,500 |
| Total | $4,564,247 |
Young received $1.5M in option awards, accounting for 34% of the total pay in 2012.
Young also received $904.4K in non-equity incentive plan, $756.3K in salary, $1.4M in stock awards and $7.5K in other compensation.
Rankings
In 2012, Kevin Young's compensation ranked 1,387th out of 11,487 executives tracked by ExecPay. In other words, Young earned more than 87.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,387 out of 11,487 | 88th |
Division Manufacturing | 505 out of 4,252 | 88th |
Major group Chemicals And Allied Products | 112 out of 1,200 | 91st |
Industry group Drugs | 62 out of 922 | 93rd |
Industry Biological Products, Except Diagnostic Substances | 8 out of 165 | 95th |
Source: SEC filing on March 24, 2014.
Young's colleagues
We found four more compensation records of executives who worked with Kevin Young at Gilead Sciences in 2012.